#United States #London #Latin America #Clarivate #API Production

Exploring Growth Opportunities in Latin America's Pharmaceutical Sector

In a recent white paper titled How is Latin America Growing?, Clarivate Plc has unveiled critical insights into the burgeoning pharmaceutical market in Latin America. The report underscores the potential for innovation and development within this field, emphasizing the necessity for strategic partnerships and increased local active pharmaceutical ingredient (API) production.

With a current valuation of approximately $98 billion, Latin America's pharmaceutical industry is projected to witness a solid growth rate of 10.1% from 2021 to 2025. This burgeoning growth comes at a time when global demand for pharmaceuticals is escalating, presenting the region with a unique opportunity to leverage its manufacturing capabilities. Clarivate highlights the conversation from industry conferences, like the 2023 and 2024 LATAM Summit held in Barcelona and CPhI Milan respectively, which called for enhanced collaboration among pharmaceutical companies, government entities, and academic institutions.

The Importance of Collaboration

According to Henry Levy, President of Life Sciences and Healthcare at Clarivate, collaboration among stakeholders—including regulators, manufacturers, and researchers—will be crucial in unlocking growth opportunities. He states, "By enhancing local pharmaceutical ecosystems through strategic partnerships and data-driven insights, we can ensure that essential therapies reach patients efficiently." Clarivate aims to provide the intelligence necessary for this transformation and bolster supply chain resilience within the region.

The Brazilian Pharmaceutical Industry Association (ABIQUIFI) plays a significant role in these discussions. Norberto Prestes, the CEO of ABIQUIFI, believes that the evolution of the industry hinges on fostering transparency and trust among partners. He emphasizes the need for investment in local API production, which could diminish reliance on imports and stimulate economic growth. Furthermore, regulatory modernization is aligned with positioning Latin America as a competitive player in the global pharmaceutical landscape.

Key Findings and Opportunities

The report outlines various key findings gathered from ongoing discussions in the sector, such as:

• - The necessity for increased transparency and collaboration in strategic partnerships.
• - The potential of local API production in minimizing import dependencies and boosting supply chain security.
• - The role that artificial intelligence can play in modernizing regulatory procedures and enhancing operational efficiency.
• - The significance of establishing consistent and long-term policies to stimulate investment and innovation within the sector.

By addressing these areas, the region can create a robust ecosystem that nurtures sustainable growth and innovation.

Looking Ahead

Clarivate is committed to supporting the life sciences and healthcare sectors within Latin America through reliable, data-driven insights. The company aims to cultivate industry dialogues and collaborative environments that contribute to sustainable innovation in the pharmaceutical field.

For a comprehensive overview of the findings presented in the report, visit Clarivate's report.

For further information on how Clarivate can assist healthcare companies in navigating the complexities of drug discovery and delivery, check this link.

About Clarivate

Clarivate stands out as a leading global provider of transformative intelligence, offering enriched data, analytics, workflow solutions, and expert services across various fields, including academia, government, intellectual property, and life sciences. For more insights into their offerings, please visit www.clarivate.com.